Gene Therapy for Primary Immunodeficiency Diseases: Recent Progress and Misgivings

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|5|549-556

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.5, 2006-02, pp. : 549-556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 2, 2016-09 ,pp. : 80-88

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects of Gene Therapy for Pulmonary Diseases: Progress and Limitations

By  

Medicinal Chemistry, Vol. 13, Iss. 4, 2017-05 ,pp. : 308-318

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects

By  

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2558-2574

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Recombinant AAV-Mediated Gene Therapy for Lung Diseases

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 361-366

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Recent Advances of Cell and Gene Therapy in Kidney Diseases

By  

Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. : 399-399

Bentham Science Publishers

Access to resources Recommend Favorite